Stock HILL HILL INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hill Incorporated

Equities

HILL

CA43147B1094

Pharmaceuticals

Market Closed - Toronto S.E.
Other stock markets
 10:35:09 2024-04-25 am EDT 		5-day change 1st Jan Change
0.29 CAD -4.92% Intraday chart for Hill Incorporated -15.94% -34.09%
Mar. 01 Hill Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Hill Incorporated Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023
Capitalization 1 17.81 9.537 15.35 5.574 5.029
Enterprise Value (EV) 1 16.74 9.681 14.81 6.834 6.363
P/E ratio -2.66 x -2.41 x -3.45 x -2.08 x -2.3 x
Yield - - - - -
Capitalization / Revenue 13.9 x 5.51 x 7 x 1.74 x 1.74 x
EV / Revenue 13.1 x 5.59 x 6.75 x 2.13 x 2.21 x
EV / EBITDA -3.75 x -2.99 x -6.41 x -3.43 x -5.81 x
EV / FCF -4.72 x -26 x -13.5 x -3.56 x -62 x
FCF Yield -21.2% -3.84% -7.41% -28.1% -1.61%
Price to Book 7.49 x 51.4 x 3.86 x 2.02 x 3.08 x
Nbr of stocks (in thousands) 1,284 1,496 2,730 2,973 3,244
Reference price 2 13.88 6.375 5.625 1.875 1.550
Announcement Date 10/28/19 10/28/20 10/28/21 10/28/22 10/23/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.6709 1.28 1.731 2.195 3.212 2.884
EBITDA 1 -2.186 -4.469 -3.24 -2.312 -1.992 -1.095
EBIT 1 -2.187 -4.52 -3.346 -2.547 -2.313 -1.397
Operating Margin -325.92% -353.03% -193.31% -116.05% -72% -48.45%
Earnings before Tax (EBT) 1 -2.653 -5.944 -3.682 -3.086 -2.578 -2.107
Net income 1 -2.653 -5.944 -3.682 -3.086 -2.578 -2.107
Net margin -395.45% -464.29% -212.71% -140.61% -80.25% -73.07%
EPS - -5.211 -2.645 -1.633 -0.9006 -0.6750
Free Cash Flow 1 -0.8046 -3.544 -0.3718 -1.097 -1.919 -0.1027
FCF margin -119.92% -276.85% -21.48% -50% -59.74% -3.56%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/31/18 10/28/19 10/28/20 10/28/21 10/28/22 10/23/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 0.14 - 1.26 1.33
Net Cash position 1 1.97 1.07 - 0.54 - -
Leverage (Debt/EBITDA) - - -0.0444 x - -0.6329 x -1.218 x
Free Cash Flow 1 -0.8 -3.54 -0.37 -1.1 -1.92 -0.1
ROE (net income / shareholders' equity) -728% -310% -287% -148% -76.6% -96%
ROA (Net income/ Total Assets) -81.2% -96.6% -83.3% -33.1% -21% -16.4%
Assets 1 3.265 6.156 4.42 9.331 12.28 12.85
Book Value Per Share 2 1.850 1.850 0.1200 1.460 0.9300 0.5000
Cash Flow per Share 2 2.670 0.8300 0.4700 1.000 0.3900 0.3700
Capex 1 0 0.28 0 0 0.08 0.01
Capex / Sales 0.43% 21.57% 0.1% 0.08% 2.58% 0.21%
Announcement Date 10/31/18 10/28/19 10/28/20 10/28/21 10/28/22 10/23/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HILL INCORPORATED Stock Hill Incorporated
-34.09% 695K
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. HILL Stock
  4. Financials Hill Incorporated